AG007QKY

21416-67-1 | 4,4'-propylenebis(piperazine-2,6-dione)

AG007QKY

SDS

COA

Price

$0.00

WARNING This product is not for human or veterinary use.

CAS Number	21416-67-1
Catalog Number	AG007QKY(AGN-PC-0JKLGY)
Chemical Name	4,4'-propylenebis(piperazine-2,6-dione)
EC Number	244-379-2
IUPAC Name	4-[2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione
InChI	InChI=1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)
InChI Key	BMKDZUISNHGIBY-UHFFFAOYSA-N
MDL Number	MFCD00430424
Molecular Formula	C11H16N4O4
Molecular Weight	268.2691
NSC Number	129943
SMILES	C(N1CC(NC(C1)=O)=O)C(N2CC(NC(C2)=O)=O)C
Synonyms	ICRF 159, ICRF 186, ICRF-159, ICRF-186, ICRF159, ICRF186, NSC 129943, NSC-129943, NSC129943, Razoxane, Razoxane Mesylate, (R)-Isomer, Razoxane, (R)-Isomer, Razoxin, Razoxane, 21416-67-1, Razoxin, 4,4'-(Propane-1,2-diyl)bis(piperazine-2,6-dione), 4,4'-Propylenebis(piperazine-2,6-dione), ICRF-159, Razoxana, Razoxanum, Tepirone, Troxozone, ICRF 159, 21416-87-5, Cardioxan, NSC129943, NSC 129943, 4,4'-propane-1,2-diyldipiperazine-2,6-dione, NSC-129943, 4,4'-Propylenebis(2,6-piperazinedione), CCRIS 344, MLS002920046, 4-[2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione, CHEBI:50225, BMKDZUISNHGIBY-UHFFFAOYSA-N, NCI-C01627, (+,-)-1,2-Bis(3,5-dioxopiperazine-1-yl)propane, EINECS 244-379-2, ICI 59118, Propylenediazmintetraessigsaeure-diimid, BRN 0821182, 2,6-Piperazinedione, 4,4'-propylenedi-, Razoxanum [INN-Latin], 1,2-Bis(3,5-dioxo-1-piperazinyl)propane, AI3-52845, Razoxana [INN-Spanish], dyzoxane, (+-)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane, (+)-dexrazoxane, 2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, C11H16N4O4, 4-[1-(3,5-dioxopiperazin-1-yl)propan-2-yl]piperazine-2,6-dione, NSC 169780, NSC-169780, Cardioxane (TN), NCGC00164737-01, Razoxane (INN), AK-72797, (+)-Razoxane, Razoxane (replaced), (+)-Razoxin, Razoxane [BAN:INN], Razoxane [INN:BAN], AC1L1JYD, DSSTox_CID_733, 2, 4,4'-propylenedi-, SCHEMBL9089, DSSTox_RID_75760, DSSTox_GSID_20733, Razoxane, >98% (HPLC), CCRIS 1271, CHEMBL444186, cpd without isomeric designation, DTXSID0020733, CTK8B5792, BCP17033, (+-)-1,5-dioxopiperazinyl)propane, Tox21_200258, 2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+-)-, ANW-50126, ICI-59118, MFCD00430424, 2, 4,4'-propylenedi-, (+-)-, AKOS015837545, (.+-.)-1,5-dioxopiperazinyl)propane, AC-1422, API0008266, TRA0025229, ACM21416875, BRN 5759130, 4,4-propylenebis(piperazine-2,6-dione), NCGC00164737-02, NCGC00164737-03, NCGC00164737-04, NCGC00164737-05, NCGC00164737-06, NCGC00164737-07, NCGC00257812-01, 2, 4,4'-propylenedi-, (.+-.)-, AK-73105, BC207848, BR-73105, NCI60_000672, SMR001797645, 1,2-bis(3,5-dioxopiperazin-1-yl)propane, AB0011451, AX8092347, CAS-21416-67-1, LS-111910, Propane,2-bis(3,5-dioxopiperazin-1-yl)-, ST2405219, TR-010040, ( -)-4.4'-Propylenedi-2,6-piperazindion, (+-)-4.4'-Propylenedi-2,6-piperazindion, 1,2-bis(3,5-dioxopiperazin-1-yl)-propane, 4CH-007190, AM20090190, FT-0083578, FT-0651500, M5146, W4448, (+-)-1,2-Bis(3,5-dioxopiperazinyl)propane, (+-)-4,4'-Propylenedi-2,6-piperazinedione, (+/-)-4,4'-Propylenedi-2,6-piperazinedione, D08471, S-7656, (+)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane, 4,4'-(propane-1,2-diyl)dipiperazine-2,6-dione, 2, 6-Piperazinedione, 4,4'-propylenedi-, (+-)-, 2,6-Piperazinedione, 4,4'-propylenedi-, (+-)-, 2,6-Piperazinedione-4,4'-propylene dioxopiperazine, J-014040, (+-)-(3,3',5'-Tetraoxo)-1,2-dipiperazinopropane, .+-.-(3,3',5'-Tetraoxo)-1,2-dipiperazinopropane, 2, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+-)-, Propane, (+-)-1,2-bis(3,5-dioxopiperazin-1-yl)-, (+-)-(3,5,3',5'-Tetraoxo)-1,2-dipiperazinopropane, 2, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (.+-.)-, 4,4`-(PROPANE-1,2-DIYL)BIS(PIPERAZINE-2,6-DIONE), Dexrazoxane, Cardioxane, Zinecard, Desrazoxane, Eucardion, razoxane mesylate, Razoxane, (R)-Isomer, Dexrazoxane hydrochloride, ICRF-186, ICRF-187, ICRF159, ICRF186, UNII-5AR83PR647, ADR-529, ICRF 186, Razoxane Mesylate, (R)-Isomer, 5AR83PR647, CID30623, 24584-09-6, LS-1003, (S)-4,4'-(Propane-1,2-diyl)bis(piperazine-2,6-dione), 2,6-PIPERAZINEDIONE,4,4'- BIS-, (+)-(S)-4,4'-Propylenedi-2,6-piperazinedione, 2,6-Piperazinedione, 4,4'-propylenedi-, (+)-, 5-24-05-00313 (Beilstein Handbook Reference), D011929, 2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+)-, 2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (S)-, 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione,

Complexity	404
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	268.117g/mol
Formal Charge	0
Heavy Atom Count	19
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	268.273g/mol
Monoisotopic Mass	268.117g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	98.8A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0
XLogP3	-1.4

GHS Hazard and Precautionary Statements

Symbol:
Hazard statements	H315-H319-H335
Precuationary statements	P261-P305+P351+P338
Siginal words

Certificate of Analysis

Lot Number